Boston Scientific’s €75m research and development investment is massive Galway boost
Galway’s thriving MedTech sector received another massive shot in the arm this week as one of the county’s biggest employers announced a €75 million investment in its Galway site.
Boston Scientific’s investment will see the expansion of its research and development capabilities – further strengthening its role as a global centre for cardiovascular innovation.
It’s also a massive boost to the critical MedTech sector generally – underlining Galway’s place at the top of that tree.
The development, supported by IDA Ireland, includes purpose-built laboratories to enhance the ability of teams in Galway to design, develop and test next-generation medical technologies across a range of cardiovascular therapies.
The expanded capability will support priority programmes across structural heart, cardiovascular and endoscopy, as well as emerging areas such as heart failure and renal denervation technologies, underpinned by a strong regional talent base and STEM ec osystem.
Minister for Education and Youth, Hildegarde Naughton, was on hand for yesterday’s announcement – and she said it showed ‘real confidence in the talent and infrastructure available here’.
It showed ‘real confidence in the talent and infrastructure available here’
“The importance of R&D and innovation to Ireland’s economy cannot be overstated. It is achieved through a strong partnership between industry, Government and IDA Ireland and has acknowledged that Galway is now an internationally recognised MedTech hub,” she said.
“This is due in no small part to the presence of Boston Scientific, which continues to invest in capabilities that advance patient care, with Galway playing a key role in delivering that innovation,” she added.
Lance Bates, executive vice president and president, Interventional Cardiology and Vascular Therapies, Boston Scientific, said that the investment reflected Galway’s role in the global giant’s success.
We are seeing strong momentum across our cardiovascular business
“We are seeing strong momentum across our cardiovascular business, and this investment reflects the important role the Galway site plays in that progress,” he said.
Boston Scientific has a long-established presence in Ireland spanning over 30 years, with over 7,000 employees across sites in Galway, Cork and Clonmel producing over 30 million devices each year for patients worldwide.